Y-Intercept (HK)’s Definium Therapeutics DFTX Stock Holding History

Y-Intercept (HK)’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.56M	Buy	+54,466	New	+$1.35M	0.05%	565
2024 Q2	–	Sell	-23,316	Closed	-$219K	–	1716
2024 Q1	$219K	Buy	23,316 +6,463	+38%	+$36.9K	0.02%	1104
2023 Q4	$61.7K	Buy	+16,853	New	+$50.7K	0.01%	1143
2022 Q3	–	Sell	-9,806	Closed	-$94K	–	1158
2022 Q2	$94K	Buy	+9,806	New	+$124K	0.01%	723

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Y-Intercept (HK)'s DFTX Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 54,466 shares worth $2.56M. The stake represents 0.05% of the portfolio and ranks #565 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in DFTX as recently as Q1 2024.

Y-Intercept (HK) first reported a position in DFTX in Q2 2022 and has held it in 4 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Y-Intercept (HK) held 54,466 shares of Definium Therapeutics worth $2.56M as of Q2 2026.
Definium Therapeutics was a new Y-Intercept (HK) position in Q2 2026.
Definium Therapeutics made up 0.05% of Y-Intercept (HK)'s portfolio in Q2 2026, its #565 holding.
Y-Intercept (HK) first reported a position in Definium Therapeutics in Q2 2022 and has held it in 4 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.